Publication | Closed Access
Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients. First line drugs vs natalizumab
35
Citations
32
References
2017
Year
Multiple Sclerosis PatientsDisease ProgressionNeurological DisorderMedicineImmunologyClinical TrialsPharmacotherapyNeurologyMultiple SclerosisFirst Line DrugsNeuroimmunology
| Year | Citations | |
|---|---|---|
Page 1
Page 1